Total Payments
$3,130
2022 Payments
$36.21
Companies
41
Transactions
192
Medicare Patients
2,458
Medicare Billing
$176,117
Payment Breakdown by Category
Food & Beverage$2,920 (93.3%)
Education$110.00 (3.5%)
Consulting$100.00 (3.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,920 | 189 | 93.3% |
| Education | $110.00 | 2 | 3.5% |
| Consulting Fee | $100.00 | 1 | 3.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $652.98 | 39 | $0 (2021) |
| Janssen Biotech, Inc. | $413.03 | 27 | $0 (2021) |
| PFIZER INC. | $297.21 | 22 | $0 (2021) |
| AbbVie, Inc. | $243.06 | 19 | $0 (2019) |
| Dendreon Pharmaceuticals LLC | $143.03 | 7 | $0 (2021) |
| Ferring Pharmaceuticals Inc. | $123.71 | 8 | $0 (2019) |
| TOLMAR Pharmaceuticals, Inc. | $122.51 | 7 | $0 (2019) |
| COMSORT, Inc | $100.00 | 1 | $0 (2019) |
| Blue Earth Diagnostics Limited | $80.33 | 5 | $0 (2021) |
| Allergan, Inc. | $65.48 | 4 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $36.21 | 2 | Antares Pharma, Inc. ($18.85) |
| 2021 | $619.82 | 39 | Janssen Biotech, Inc. ($123.29) |
| 2020 | $372.54 | 20 | Janssen Biotech, Inc. ($137.03) |
| 2019 | $861.55 | 48 | Astellas Pharma US Inc ($162.55) |
| 2018 | $612.67 | 38 | Astellas Pharma US Inc ($260.94) |
| 2017 | $626.89 | 45 | AbbVie, Inc. ($176.02) |
All Payment Transactions
192 individual payment records from CMS Open Payments — Page 3 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/03/2020 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: ONCOLOGY | ||||||
| 03/11/2020 | Antares Pharma, Inc. | OTREXUP (Drug) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: Rheumatoid Arthritis | ||||||
| 03/03/2020 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: Oncology | ||||||
| 02/27/2020 | Coloplast Corp | SPEEDICATH (Device) | Food and Beverage | Cash or cash equivalent | $17.51 | General |
| Category: CONTINENCE | ||||||
| 02/19/2020 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $29.80 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 02/18/2020 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: Oncology | ||||||
| 02/11/2020 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: UROLOGY | ||||||
| 02/06/2020 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: ONCOLOGY | ||||||
| 01/15/2020 | PFIZER INC. | XTANDI (Drug) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: ONCOLOGY | ||||||
| 01/09/2020 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: Oncology | ||||||
| 01/09/2020 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $12.31 | General |
| Category: ONCOLOGY | ||||||
| 12/18/2019 | Boston Scientific Corporation | REZUM (Device) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: PROSTATE HEALTH | ||||||
| 12/12/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Oncology | ||||||
| 12/03/2019 | PFIZER INC. | XTANDI (Drug) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: ONCOLOGY | ||||||
| 11/26/2019 | Astellas Pharma US Inc | — | Education | In-kind items and services | $55.00 | General |
| 11/20/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: UROLOGY | ||||||
| 11/14/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: Oncology | ||||||
| 11/08/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $5.28 | General |
| Category: Oncology | ||||||
| 10/23/2019 | ROCHESTER MEDICAL CORPORATION | — | Food and Beverage | In-kind items and services | $14.59 | General |
| 10/21/2019 | PFIZER INC. | XTANDI (Drug) | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: ONCOLOGY | ||||||
| 10/10/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Oncology | ||||||
| 09/25/2019 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $28.44 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 09/19/2019 | PFIZER INC. | XTANDI (Drug) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: ONCOLOGY | ||||||
| 09/11/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: Oncology | ||||||
| 08/28/2019 | Allergan Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: HYPERHYDROSIS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 15 | 967 | 1,236 | $167,083 | $62,665 |
| 2020 | 25 | 1,491 | 2,024 | $332,842 | $113,452 |
Total Patients
2,458
Total Services
3,260
Medicare Billing
$176,117
Procedure Codes
40
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 169 | 208 | $44,998 | $17,924 | 39.8% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2021 | 55 | 63 | $28,369 | $11,649 | 41.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 148 | 174 | $25,974 | $11,314 | 43.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 44 | 45 | $18,315 | $7,164 | 39.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 51 | 51 | $16,902 | $4,959 | 29.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 31 | 42 | $6,126 | $2,400 | 39.2% |
| 51702 | Insertion of indwelling bladder catheter, simple | Office | 2021 | 11 | 33 | $4,290 | $1,542 | 35.9% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 34 | 37 | $3,373 | $1,492 | 44.2% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 28 | 36 | $2,859 | $1,099 | 38.4% |
| 81003 | Automated urinalysis test | Office | 2021 | 276 | 418 | $5,112 | $927.00 | 18.1% |
| 76770 | Ultrasound behind abdominal cavity | Office | 2021 | 11 | 11 | $4,950 | $916.20 | 18.5% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2021 | 53 | 60 | $2,492 | $456.50 | 18.3% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 17 | 18 | $776.00 | $293.28 | 37.8% |
| 74420 | Imaging of urinary tract | Facility | 2021 | 14 | 14 | $1,136 | $280.28 | 24.7% |
| 51741 | Electronic assessment of bladder emptying | Office | 2021 | 25 | 26 | $1,411 | $249.25 | 17.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 248 | 356 | $77,120 | $26,845 | 34.8% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2020 | 14 | 96 | $53,592 | $16,864 | 31.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 226 | 269 | $40,135 | $13,408 | 33.4% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2020 | 67 | 73 | $32,907 | $11,692 | 35.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 91 | 91 | $30,210 | $10,656 | 35.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 60 | 62 | $25,234 | $9,866 | 39.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 44 | 62 | $9,035 | $3,604 | 39.9% |
| 51728 | Insertion of electronic device into bladder with voiding pressure studies | Office | 2020 | 11 | 11 | $7,106 | $2,964 | 41.7% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 20 | 21 | $6,153 | $2,464 | 40.0% |
| 55700 | Biopsy of prostate gland | Office | 2020 | 11 | 11 | $5,566 | $1,990 | 35.8% |
About Dr. Scott Sell, M.D
Dr. Scott Sell, M.D is a Urology healthcare provider based in Fredericksburg, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1134176563.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Sell, M.D has received a total of $3,130 in payments from pharmaceutical and medical device companies, with $36.21 received in 2022. These payments were reported across 192 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($2,920).
As a Medicare-enrolled provider, Sell has provided services to 2,458 Medicare beneficiaries, totaling 3,260 services with total Medicare billing of $176,117. Data is available for 2 years (2020–2021), covering 40 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Fredericksburg, VA
- Active Since 05/30/2006
- Last Updated 01/21/2011
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1134176563
Products in Payments
- XTANDI (Drug) $370.54
- ERLEADA (Drug) $260.32
- MYRBETRIQ (Drug) $209.63
- Androgel (Drug) $196.01
- KEYTRUDA (Biological) $143.49
- PROVENGE (Drug) $143.03
- Erleada (Drug) $129.44
- FIRMAGON (Drug) $123.71
- ELIGARD (Drug) $122.51
- Axumin (Drug) $80.33
- TOVIAZ (Drug) $72.57
- Myrbetriq (Drug) $72.21
- Natesto (Drug) $51.45
- Prolia (Biological) $50.04
- GentleCath (Device) $49.41
- BOTOX (Biological) $48.95
- Xtandi (Drug) $35.76
- iTIND System (Device) $34.73
- Lupron Depot (Drug) $32.67
- SUTENT (Drug) $31.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Fredericksburg
Daniel Hoffman, M.d, M.D
Urology — Payments: $8,905
Urology $8,905
Dr. Charles Beamon, Md, MD
Urology — Payments: $8,429
Urology $8,429
Gregory Szlyk, M.d, M.D
Urology — Payments: $8,195
Urology $8,195
Frank Hill
Urology — Payments: $7,038
Urology $7,038
Matthew Dumont, M.d, M.D
Urology — Payments: $6,442
Urology $6,442
Elmore Becker, Md, MD
Urology — Payments: $5,610
Urology $5,610